Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Amidazophen. Yes or no?]

J Jákó1, G Arató

  • 1Pathologiai Intézet, Haynal Imre Egészségtudományi Egyetem I. Belgyógyászati Klinika.

Orvosi Hetilap
|September 24, 1995
PubMed
Summary
This summary is machine-generated.

Amidazophen is a preferred fever reducer over Paracetamol due to professional and cost benefits. A case study links Paracetamol use to acute tubular necrosis, suggesting kidney damage risks.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Progesterone-induced blocking factor (PIBF) and trophoblast invasiveness.

Journal of reproductive immunology·2011
Same author

Identification of P-selectin glycoprotein ligand-1 as a useful marker in acute myeloid leukaemias.

British journal of haematology·2002
Same author

Ewing's sarcoma in the nasal cavity.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2001
Same author

[Role of thalidomide in the treatment of multiple myeloma].

Orvosi hetilap·2001
Same author

[Isolated gastroduodenal Crohn's disease: a case report].

Magyar sebeszet·2001
Same author

Placental site trophoblastic tumor. Clinical and pathological report of two cases.

Pathology oncology research : POR·2001
Same journal

[The application of artificial intelligence in healthcare: benefits, challenges, and issues of responsibility].

Orvosi hetilap·2026
Same journal

[Long-COVID syndrome and lung-specific abnormalities following COVID-19].

Orvosi hetilap·2026
Same journal

[Validation of the Vaccination Attitudes Examination (VAX) scale in Hungary].

Orvosi hetilap·2026
Same journal

Orvosi hetilap·2026
Same journal

[The Hungarian short version and psychometric properties of the Activities-specific Balance Confidence Scale for assessing fall risk].

Orvosi hetilap·2026
Same journal

[Hungarian primary care: facts, problems and expectations].

Orvosi hetilap·2026
See all related articles

Area of Science:

  • Pharmacology
  • Nephrology

Background:

  • Comparison of antipyretic medications Paracetamol and Amidazophen.
  • Evaluation of side effects and hazards based on existing literature.

Observation:

  • Analysis of literary data regarding Paracetamol and Amidazophen.
  • Inclusion of a case study involving acute tubular necrosis.

Findings:

  • Amidazophen is recommended as a more effective and cost-efficient antipyretic.
  • A potential causal link between Paracetamol and kidney damage is identified.

Implications:

  • Clinical practice may favor Amidazophen for fever management.
  • Further research into Paracetamol's nephrotoxicity is warranted.